Jen Smith

Jen Smith is the medical editor of Cancer Therapy Advisor. She was previously the editor of Hematology Times and the oncology editor for MDedge Hematology/Oncology. She has a BS in journalism.

All articles by Jen Smith

Urology

Risk of Drug-Drug Interactions in Patients With HIV and Cancer

Jen Smith

May 9, 2023

As many as 1 in 4 patients receiving treatment for cancer and HIV may be at risk of experiencing drug-drug interactions, according to researchers.

Bladder Cancer

How the BCG Shortage Has Affected Patients With Bladder Cancer

Jen Smith

April 17, 2023

After the BCG shortage began, patients with non-muscle invasive bladder cancer were less likely to receive a full course of induction with any drug.

Bladder Cancer

Cost of Radical Cystectomy Higher in the West Than in Other US Regions

Jen Smith

April 3, 2023

Total hospital costs related to radical cystectomy are higher in the West than in all other regions of the United States, a study suggests.

Kidney Cancer

Long-Term Data Support Frontline Avelumab and Axitinib for Advanced RCC

Jen Smith

January 20, 2023

Combination avelumab and axitinib has shown long-term activity in previously untreated patients with advanced renal cell carcinoma.

Prostate Cancer

Controversy Prompts Another Update to NCCN Guidelines for Prostate Cancer

Jen Smith

December 15, 2021

After physicians voiced concerns about an active surveillance recommendation, the NCCN panel revised the guidelines.

Next post in Prostate Cancer

Jen Smith

All articles by Jen Smith

Risk of Drug-Drug Interactions in Patients With HIV and Cancer

How the BCG Shortage Has Affected Patients With Bladder Cancer

Cost of Radical Cystectomy Higher in the West Than in Other US Regions

Long-Term Data Support Frontline Avelumab and Axitinib for Advanced RCC

Controversy Prompts Another Update to NCCN Guidelines for Prostate Cancer

Shared Medical Appointments Feasible, Acceptable for Active Surveillance Management of Prostate Cancer